1. Home
  2. VRE vs IVA Comparison

VRE vs IVA Comparison

Compare VRE & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veris Residential Inc.

VRE

Veris Residential Inc.

HOLD

Current Price

$14.75

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$6.89

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRE
IVA
Founded
1949
2011
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
VRE
IVA
Price
$14.75
$6.89
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$18.67
$16.00
AVG Volume (30 Days)
592.8K
602.4K
Earning Date
02-23-2026
09-29-2025
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$291,348,000.00
$19,929,536.00
Revenue This Year
$4.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.79
N/A
Revenue Growth
6.39
N/A
52 Week Low
$13.69
$2.15
52 Week High
$17.18
$7.98

Technical Indicators

Market Signals
Indicator
VRE
IVA
Relative Strength Index (RSI) 47.50 72.20
Support Level $14.61 $6.76
Resistance Level $15.23 $7.29
Average True Range (ATR) 0.32 0.35
MACD -0.01 0.11
Stochastic Oscillator 29.26 82.41

Price Performance

Historical Comparison
VRE
IVA

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: